Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Ibuprofen for PDA in Preterm Infants
NCT01243996Phase 3Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Jun 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Università degli Studi di Firenze. Started Jun 2008; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT01243996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243996.